Ignite Creation Date:
2024-05-06 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 12:54 PM
Study NCT ID:
NCT03671330
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-21
First Post:
2018-09-12
Brief Title:
Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive HER2-negative Advanced Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-29
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-15
Completion Date Type:
ESTIMATED
First Submit Date:
2018-09-12
First Submit QC Date:
September 12 2018
Study First Post Date:
2018-09-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-09
Last Update Post Date:
2024-05-21
Last Update Post Date Type:
ACTUAL